Interaction trimethoprim-sulfamethoxazole methotrexate children leukemia trimethoprim-sulfamethoxazole TMP-SMX neutropenia children leukemia possibility pharmacokinetic interaction methotrexate MTX TMP-SMX causes accumulation antileukemia agent pharmacokinetics MTX children acute lymphoblastic leukemia TMP-SMX increase free MTX fraction TMP-SMX therapy patients mean SD TMP-SMX TMP-SMX Plasma clearance total MTX whereas clearance free MTX ml/kg/min consistent decrease renal clearance free MTX ml/kg/min Elimination half-life MTX TMP-SMX significant correlation serum concentrations TMP-SMX percentage decrease renal clearance free MTX changes protein binding tubular clearance MTX competition TMP-SMX result mean increase systemic exposure MTX myelotoxicity coadministration drugs 